Deutsche Bank’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-26,287
| Closed | -$1.04M | – | 5270 |
|
|
2016
Q3 | $1.04M | Buy |
26,287
+5,865
| +29% | +$65.4K | ﹤0.01% | 2800 |
|
|
2016
Q2 | $255K | Buy |
20,422
+16,576
| +431% | +$154K | ﹤0.01% | 3638 |
|
|
2016
Q1 | $30K | Sell |
3,846
-2,862
| -43% | -$21.6K | ﹤0.01% | 4515 |
|
|
2015
Q4 | $66K | Sell |
6,708
-75
| -1% | -$779 | ﹤0.01% | 4268 |
|
|
2015
Q3 | $64K | Sell |
6,783
-22,361
| -77% | -$314K | ﹤0.01% | 4324 |
|
|
2015
Q2 | $501K | Buy |
29,144
+141
| +0.5% | +$2.06K | ﹤0.01% | 3395 |
|
|
2015
Q1 | $317K | Buy |
29,003
+24,713
| +576% | +$265K | ﹤0.01% | 3547 |
|
|
2014
Q4 | $34K | Buy |
4,290
+4,274
| +26,713% | +$36.8K | ﹤0.01% | 5322 |
|
|
2014
Q3 | $0 | Sell |
16
-334
| -95% | -$6.6K | ﹤0.01% | 6267 |
|
|
2014
Q2 | $20K | Sell |
350
-3,568
| -91% | -$217K | ﹤0.01% | 5318 |
|
|
2014
Q1 | $441K | Sell |
3,918
-1,446
| -27% | -$101K | ﹤0.01% | 3412 |
|
|
2013
Q4 | $229K | Buy |
5,364
+2,344
| +78% | +$110K | ﹤0.01% | 3625 |
|
|
2013
Q3 | $181K | Buy |
+3,020
| New | +$158K | ﹤0.01% | 4165 |
|
Deutsche Bank's TBRA Position: Q4 2016 in Review
Deutsche Bank sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 26,287 shares — an estimated $1.04M sold.
Deutsche Bank first reported a position in TBRA in Q3 2013 and held it in 13 quarters. The position peaked at $1.04M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.
- Deutsche Bank reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
- Deutsche Bank sold 26,287 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.04M.
- Deutsche Bank first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 13 quarters.
- Deutsche Bank's Tobira Therapeutics, Inc. Common Stock position peaked at $1.04M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.
Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.